Cargando…

MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases

BACKGROUND: The efficacy of salvage resection (SR) of recurrent brain metastases (BrM) post-stereotactic radiosurgery (SRS) is not well described. We sought to characterize the impact of adjuvant post-salvage radiation therapy (PSRT) in this setting and identify tumor-specific variables that influen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilcox, Jessica, Brown, Samantha, Reiner, Anne, Young, Robert, Chen, Justin, Bale, Tejus, Rosenblum, Marc, Newman, William, Brennan, Cameron, Tabar, Viviane, Beal, Kathryn, Panageas, Katherine, Moss, Nelson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351198/
http://dx.doi.org/10.1093/noajnl/vdab071.054
_version_ 1783735921820041216
author Wilcox, Jessica
Brown, Samantha
Reiner, Anne
Young, Robert
Chen, Justin
Bale, Tejus
Rosenblum, Marc
Newman, William
Brennan, Cameron
Tabar, Viviane
Beal, Kathryn
Panageas, Katherine
Moss, Nelson
author_facet Wilcox, Jessica
Brown, Samantha
Reiner, Anne
Young, Robert
Chen, Justin
Bale, Tejus
Rosenblum, Marc
Newman, William
Brennan, Cameron
Tabar, Viviane
Beal, Kathryn
Panageas, Katherine
Moss, Nelson
author_sort Wilcox, Jessica
collection PubMed
description BACKGROUND: The efficacy of salvage resection (SR) of recurrent brain metastases (BrM) post-stereotactic radiosurgery (SRS) is not well described. We sought to characterize the impact of adjuvant post-salvage radiation therapy (PSRT) in this setting and identify tumor-specific variables that influence local control. METHODS: Retrospective analysis of post-SRS recurrent BrM that underwent SR between 2003–2020 at Memorial Sloan Kettering Cancer Center was performed. Cases with histologically-viable malignancy were included and stratified by receipt of adjuvant PSRT within 60 days of SR (PSRT cohort) vs. observation (observation cohort). Resection-site outcomes were described using cumulative incidences and univariate and multivariate competing risks regression accounting for clustering. RESULTS: One-hundred fifty-five recurrent BrM in 135 patients were included. Thirty-nine (25.2%) of the post-operative cavities were treated with adjuvant PSRT, and the remaining 116 (74.8%) cavities were initially observed. Gross- or near-total resection was associated with significantly improved local control compared to subtotal resection (p=0.007). Adjuvant PSRT was associated with a reduced rate of LR at 6 months [18.0% (95%CI: 9.8–33.1%) vs. 35.9% (95%CI: 27.9–46.2%) with initial observation] and 12 months [28.8% (95%CI: 17.0–48.8%) vs. 43.9% (95%CI: 36.2–53.4%)]. On multivariate analysis, adjuvant PSRT (p=0.095), low tumor-viability within the resected BrM (p=0.17), and first-time resection (p=0.035) all independently trended towards improved local control. BrM size at SR (≥3cm vs. <3cm, p=0.48), primary malignancy (p=0.35), and specific PSRT modality (whole or partial brain radiation vs. SRS, p=0.43) were not associated with differences in LR rate. Radiation necrosis (RN) was significantly increased in the PSRT cohort (HR 4.55, 95%CI: 1.26–16.39, p=0.02), though the total percentage with symptomatic RN remained low (PSRT cohort 5.1% vs observation cohort 0.9%). CONCLUSIONS: Local control after SR of a recurrent BrM may be optimized with gross- or near-total resection and adjuvant post-operative re-irradiation, with low symptomatic RN.
format Online
Article
Text
id pubmed-8351198
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-83511982021-08-09 MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases Wilcox, Jessica Brown, Samantha Reiner, Anne Young, Robert Chen, Justin Bale, Tejus Rosenblum, Marc Newman, William Brennan, Cameron Tabar, Viviane Beal, Kathryn Panageas, Katherine Moss, Nelson Neurooncol Adv Supplement Abstracts BACKGROUND: The efficacy of salvage resection (SR) of recurrent brain metastases (BrM) post-stereotactic radiosurgery (SRS) is not well described. We sought to characterize the impact of adjuvant post-salvage radiation therapy (PSRT) in this setting and identify tumor-specific variables that influence local control. METHODS: Retrospective analysis of post-SRS recurrent BrM that underwent SR between 2003–2020 at Memorial Sloan Kettering Cancer Center was performed. Cases with histologically-viable malignancy were included and stratified by receipt of adjuvant PSRT within 60 days of SR (PSRT cohort) vs. observation (observation cohort). Resection-site outcomes were described using cumulative incidences and univariate and multivariate competing risks regression accounting for clustering. RESULTS: One-hundred fifty-five recurrent BrM in 135 patients were included. Thirty-nine (25.2%) of the post-operative cavities were treated with adjuvant PSRT, and the remaining 116 (74.8%) cavities were initially observed. Gross- or near-total resection was associated with significantly improved local control compared to subtotal resection (p=0.007). Adjuvant PSRT was associated with a reduced rate of LR at 6 months [18.0% (95%CI: 9.8–33.1%) vs. 35.9% (95%CI: 27.9–46.2%) with initial observation] and 12 months [28.8% (95%CI: 17.0–48.8%) vs. 43.9% (95%CI: 36.2–53.4%)]. On multivariate analysis, adjuvant PSRT (p=0.095), low tumor-viability within the resected BrM (p=0.17), and first-time resection (p=0.035) all independently trended towards improved local control. BrM size at SR (≥3cm vs. <3cm, p=0.48), primary malignancy (p=0.35), and specific PSRT modality (whole or partial brain radiation vs. SRS, p=0.43) were not associated with differences in LR rate. Radiation necrosis (RN) was significantly increased in the PSRT cohort (HR 4.55, 95%CI: 1.26–16.39, p=0.02), though the total percentage with symptomatic RN remained low (PSRT cohort 5.1% vs observation cohort 0.9%). CONCLUSIONS: Local control after SR of a recurrent BrM may be optimized with gross- or near-total resection and adjuvant post-operative re-irradiation, with low symptomatic RN. Oxford University Press 2021-08-09 /pmc/articles/PMC8351198/ http://dx.doi.org/10.1093/noajnl/vdab071.054 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Abstracts
Wilcox, Jessica
Brown, Samantha
Reiner, Anne
Young, Robert
Chen, Justin
Bale, Tejus
Rosenblum, Marc
Newman, William
Brennan, Cameron
Tabar, Viviane
Beal, Kathryn
Panageas, Katherine
Moss, Nelson
MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
title MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
title_full MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
title_fullStr MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
title_full_unstemmed MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
title_short MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
title_sort mlti-05. adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
topic Supplement Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351198/
http://dx.doi.org/10.1093/noajnl/vdab071.054
work_keys_str_mv AT wilcoxjessica mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT brownsamantha mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT reineranne mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT youngrobert mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT chenjustin mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT baletejus mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT rosenblummarc mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT newmanwilliam mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT brennancameron mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT tabarviviane mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT bealkathryn mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT panageaskatherine mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases
AT mossnelson mlti05adjuvantreirradiationimproveslocalcontrolofsurgicallyresectedrecurrentbrainmetastases